Drug Research
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial...
Press Releases
Dr Reddy’s Lab gets emergency use authorisation for Sputnik V in India
Dr. Reddyโs Laboratories Ltd. announced that it has received the permission from the Drug Controller General of India(DCGI)to import the Sputnik vaccine into India...
Drug Research
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
Sanofi announced a โฌ400 million investment over five years to create a unique vaccine production center in Singapore, pushing the boundaries of operations through...
News
Malvern Panalytical and Concept Life Sciences announce integration
Malvern Panalytical, manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration. The...
News
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyrs Anti-NRP2 Antibody ATYR2810
โAs we prepare to advance ATYR2810 to clinical stage development, we are pleased to work with Lonza, a partner with extensive and proven capability...
Clinical Trials
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced clinical and supply updates on its COVID-19 Vaccine program. New results...
News
Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of complex biologics and bioconjugates has announced that the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read













